Status:
COMPLETED
Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Down Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.
Eligibility Criteria
Inclusion
- Female \> 18 years old
- Pregnant
Exclusion
- Maternal age \< 18 years old, twin pregnancy
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT00287417
Start Date
July 1 2003
End Date
February 1 2011
Last Update
May 16 2011
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Département de Gynécologie-Obstétrique, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, Alsace, France, 67098
2
Service de Gynécologie-Obstétrique, SIHCUS, CMCO
Strasbourg, Alsace, France, 67303
3
Centre Hospitalier
Belfort, France, 90000
4
Centre Mère et Enfant LE PARC, Service de Gynécologie Obstétrique
Colmar, France, 68024